Mia M. Gaudet, PhD, of Rollins School of Public Health
"The Genetics of Breast Cancer from Rare to Common"
November 8, 2017
Nadine M. Tung, MD, of Harvard Medical School
"Managing Hereditary Breast Cancer"
November 1, 2017
S. Vincent Rajkumar, MD of Mayo Clinic
"The Evolution of Myeloma: Current insights on Biology and Therapy"
October 25, 2017
Emiel Janssen, PhD of Stavanger University
"The Norwegian Prospective Breast Cancer Biobanking Program: Prospective and Long-Term Predictive and Prognostic Biomarker Discovery in Breast Cancer Patients"
September 20, 2017
R. Donald Harvey, PharmD of Emory University School of Medicine
"Biosimilars in Oncology: Considerations from Development to Treatment"
September 13, 2017
Alan Pollack, MD, PhD of University of Miami
"Post-Prostatectomy Radiotherapy for Prostate Cancer"
August 30, 2017
Mitch Phelps, PhD of Ohio State University
"The Clinical Role of Transporters in Resistance: IMiDs as Case Examples"
August 23, 2017
Mehmet Asim Bilen, MD of Emory University School of Medicine
"Updates in Genitourinary Oncology"
July 19, 2017
Tracy Todd Batchelor, MD, MPH of Harvard Medical School
"Update on Primary CNS Lymphoma"
July 12, 2017
"Higher Level Pathway Objectives of Epigenetic Therapy - A Solution for the P53 Problem in Cancer"
June 28, 2017
The Emory University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Emory University School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.